Anti-Trust Concerns with Cigna-Anthem Merger

The $50 billion merger between insurance giants Cigna and Anthem has been in the works for almost a year now. Although critics have been doubtful that this merger will go through due to anti-trust issues, it seems that federal regulators are publicly demonstrating disdain for this move.

As the companies continue to wade through regulatory push back, another major deal is also being reviewed, which is much smaller by comparison. The Aetna-Humana merger is a $37 billion deal that appears to have less obstacles to tackle due to it being a smaller transaction.

Continue reading